A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden
Phase of Trial: Phase IV
Latest Information Update: 05 Jun 2017
Price : $35 *
At a glance
- Drugs Liraglutide (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Therapeutic Use
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 25 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Apr 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.